KEYTRUDA INJECTION 100 mg/4ml

KEYTRUDA 100mg/4mL Injection contains pembrolizumab, an immunotherapy medicine known as a programmed death-1 (PD-1) inhibitor. It helps the body's immune system recognize and attack certain cancer cells by blocking the PD-1 pathway.

Common Uses

KEYTRUDA may be used alone or with other treatments for certain types of cancer, including:

• Melanoma
• Non-small cell lung cancer
• Head and neck squamous cell carcinoma
• Classical Hodgkin lymphoma
• Urothelial cancer
• Kidney cancer
• Triple-negative breast cancer
• Certain colorectal cancers
• Endometrial cancer

Side Effects

Common side effects may include fatigue, diarrhea or constipation, nausea, reduced appetite, rash, itching, muscle or joint pain, cough, shortness of breath and fever. Serious reactions can include inflammation affecting the lungs, colon, liver, kidneys or hormone glands, as well as severe infusion or skin reactions. Disclaimer: This information is for educational purposes only and should not be considered medical advice. KEYTRUDA should be used under the supervision of a qualified healthcare professional.